Companies Dominating the Oral Hydrogel Wound Dressing Landscape
- Integra LifeSciences Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Cardinal Health, Inc.
- Medline Industries, LP
- Coloplast A/S
- Smith & Nephew
- AMERX Health Care Corp.
- B. Braun Melsungen AG
- Mölnlycke Health Care AB
- PAUL HARTMANN AG
- DermaRite Industries, LLC.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of oral hydrogel wound dressing is assessed at USD 939.08 million.
The oral hydrogel wound dressing market size was valued at USD 823.3 million in 2024 and is expected to reach USD 2.37 billion by 2037, expanding at around 8.5% CAGR during the forecast period i.e., between 2025-2037. The growing demand for effective wound care and infection control in primary healthcare settings, and the increasing prevalence of post-surgical wounds will propel the market growth.
North America industry is likely to hold largest revenue share of 36% by 2037, on the back of rising prevalence of chronic wounds such as pressure ulcers, diabetic ulcers, coupled with rising healthcare expenditure.
The major players in the market are Integra LifeSciences Corporation, Cardinal Health, Inc., Medline Industries, LP, Coloplast A/S, Smith & Nephew, AMERX Health Care Corp., B. Braun Melsungen AG, Mölnlycke Health Care AB, PAUL HARTMANN AG, DermaRite Industries, LLC, .
